TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa
Science Advances · 29.05.2026 · 12 (22)
DOI: 10.1126/sciadv.aea6467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 29.05.2026. Verfasst von Rong Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry, The Hong Kong Polytechnic University, Hong Kong, China. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, Cytoskeleton, Tropomyosin, Leukocyte Common Antigens. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: General Research Fund (GRF) from the Hong Kong Research Grants Council.
Abstract (Originalsprache)
Retinitis pigmentosa (RP), the most prevalent inherited retinal degeneration, features progressive photoreceptor loss with no approved disease-modifying therapies. While microglia-driven neuroinflammation accelerates RP progression, its sustaining mechanisms remain elusive. Through integrated multiomics profiling of retinal degeneration 10 (rd10) mice, we identify tropomyosin 1 (TPM1) as a previously unrecognized cytoskeletal-immune regulator orchestrating spatial neuroinflammation in RP. Genetic ablation of Tpm1 attenuated microglial reactivity and preserved vision, whereas overexpression triggered self-reinforcing inflammation via four interlocked axes: (i) TPM1-mediated activator protein-1 (AP-1) hyperactivation initiates senescence-associated secretory phenotype (SASP) through mitogen-activated protein kinase (MAPK) kinase/extracellular signal–regulated kinase 3–dependent MAPK signaling; (ii) SASP subsequently mediates reduced phagocytosis; (iii) Tpm1-Apoe/Fabp5 axis disruption precipitates lipid droplet accumulation with cholesterol crystallization; (iv) galectin-9 (LGALS9)/CD45-mediated intermicroglial signaling propagates inflammatory signals across the retina. Our work redefines TPM1 as a linchpin in self-sustaining neurodegeneration cycles, where cytoskeletal dysfunction fuels immunometabolic collapse. These findings unveil precision therapeutic strategies targeting TPM1 hubs—notably the LGALS9/CD45 axis—to disrupt inflammatory cycles while preserving retinal homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Optometry, The Hong Kong Polytechnic University, Hong Kong, China.
- Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Hong Kong, China.
Förderung
- General Research Fund (GRF) from the Hong Kong Research Grants Council
Zitieren
APA
Li, R., Fan, J. Q., & Lin, B. (2026). TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa. Science Advances, 12(22). https://doi.org/10.1126/sciadv.aea6467
Vancouver
Li R, Fan JQ, Lin B. TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa. Science Advances. 2026;12(22). doi:10.1126/sciadv.aea6467
BibTeX
@article{Li2026,
author = {Li, Rong and Fan, Jun-Qi and Lin, Bin},
title = {TPM1 drives cytoskeleton-immunometabolism coupling and LGALS9/CD45-mediated neuroinflammatory propagation in retinitis pigmentosa},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {22},
doi = {10.1126/sciadv.aea6467}
}
EUVIMED